Combination of bFGF, heparin and laminin induce the generation of dopaminergic neurons from rat neural stem cells both in vitro and in vivo

Journal of the Neurological Sciences

Volumn 255, Issue 1-2, 2007, Pages 81-86

  Yu, Yiqun ^a   Gu, Shuting ^a   Huang, Hai ^a   Wen, Tieqiao ^a  

^a SHANGHAI UNIVERSITY   (China)

Author keywords

bFGF; Cell transplantation; Differentiation; Dopaminergic neurons; Heparin; Laminin; Neural stem cells

Indexed keywords

ASCORBIC ACID; BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; HEPARIN; LAMININ; MICROTUBULE ASSOCIATED PROTEIN 2; OXIDOPAMINE; POLYLYSINE; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CULTURE MEDIUM; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; NERVE CELL; NEURAL STEM CELL; NEUROLOGIC DISEASE; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; STEM CELL TRANSPLANTATION;

ANIMALS; ANIMALS, NEWBORN; BRAIN TISSUE TRANSPLANTATION; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; DOPAMINE; FIBROBLAST GROWTH FACTOR 2; GRAFT SURVIVAL; HEPARIN; LAMININ; NERVE GROWTH FACTORS; NEURONS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; STEM CELL TRANSPLANTATION; STEM CELLS; SUBSTANTIA NIGRA;

EID: 33947189677     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.01.076     Document Type: Article

References (26)

1. Sally T. The development of neural stem cells. Nature 414 (2001) 112-117
2. Caldwell M.A., He X., Wilkie N., Pollack S., Marshall G., Wafford K.A., et al. Growth factors regulate the survival and fate of cells derived from human neurospheres. Nat Biotechnol 19 (2001) 475-479
3. Gage F.H. Mammalian neural stem cells. Science 287 (2000) 1433-1438
4. Shimazaki T., Shingo T., and Weiss S. The ciliary neurotrophic factor/leukemia inhibitory factor/gp130 receptor complex operates in the maintenance of mammalian forebrain neural stem cells. J Neurosci 21 (2001) 7642-7653
5. Arenas E. Stem cells in the treatment of Parkinson's disease. Brain Res Bull 57 (2002) 795-808
6. Bjorklund L.M., Pernaute R.S., Chung S., Andersson T., Chen I.Y.C., McNaught K., et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 99 (2002) 2344-2349
7. Hideyuki O., Takahito Y., Takuya S., and Kazunobu S. Isolation and transplantation of dopaminergic neurons and neural stem cells. Parkinsonism Relat Disord 9 (2002) 23-28
8. Shihabuddin L.S., Ray J., and Gage F.H. Stem cell technology for basic science and clinical applications. Arch Neurol 56 (1999) 29-32
9. Whittemore S.R., Morassutti D.J., Walters W.M., Liu R.H., and Magnuson S.K. Mitogen and substrate differentially affect the lineage restriction of adult rat subventricular zone neural precursor cell populations. Exp Cell Res 252 (1999) 75-95
10. Fannon M., Forsten K.E., and Nugent M.A. Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response. Biochemistry 39 (2000) 1434-1445
11. Kan M., Wang F., Xu J., Crabb J.W., Hou J., and Mckeehan W.L. An essential heparin-binding domain in the fibroblast growth-factor receptor kinase. Science 259 (1993) 1918-1921
12. Darren J.M., Andrew B.W., Valina L.D., and Ted M.D. Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci 28 (2005) 57-87
13. Mohammad H., Yashar S., and Shahriar G. Modeling the Parkinson tremor and its treatments. J Theor Biol 236 (2005) 311-322
14. Petroske E., Meredith G.E., Callen S., Totterdell S., and Lau Y.S. Mouse model of Parkinsonism: a comparison between subacute mptp and chronic mptp/probenecid treatment. Neuroscience 106 (2001) 589-601
15. Elizabeth A.M., Noelle P.L., and Leonard I.Z. The clinical potential of stem cells. Curr Opin Cell Biol 16 (2004) 713-720
16. Carman L.S., Gage F.H., and Shults C.W. Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior. Brain Res 553 (1991) 275-283
17. Kim J.H., Jonathan M.A., Rodríguez-Gómez J.A., Iván V., Denise G., Nadya L., et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nautre 418 (2002) 50-56
18. Olanow C.W., Kordower J.H., and Freeman T.B. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci 19 (1996) 102-109
19. Paul C.B., and Schindehutte J. Behavioral changes in unilaterally 6-hydroxy-dopamine lesioned rats after transplantation of differentiated mouse embryonic stem cells without morphological integration. Stem Cells 22 (2004) 396-404
20. Marina E.E. Evaluation of animal models of Parkinson's disease for neuroprotective strategies. J Neurosci Methods 139 (2004) 121-143
21. Ranjita B., Todd B.S., and Greenamyre J.T. Animal models of Parkinson's disease. BioEssays 24 (2002) 308-318
22. Isabel L., Elisa G.G., and Alberto M.S. The generation of dopaminergic neurons by human neural stem cells is enhanced by Bcl-XL, both in vitro and in vivo. J Neurosci 24 (2004) 10786-10795
23. Thor O., and Clive N.S. Requirement for neurogenesis to proceed through the division of neuronal progenitors following differentiation of epidermal growth factor and fibroblast growth factor-2-responsive human neural stem cells. Stem Cells 22 (2004) 798-811
24. Damier P., Hirsch E.C., Agid Y., and Graybiel A.M. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 122 (1999) 1437-1448
25. Maingay M., Romero-Ramos M., and Kirik D. Viral vector mediated overexpression of human alpha-synuclein in the nigrostriatal dopaminergic neurons: a new model for Parkinson's disease. CNS Spectr 10 3 (2005) 235-244
26. Patrik B., and Anders B. Survival of expanded dopaminergic precursors is critical for clinical trials. Nature Neurosci 1 (1998) 537